相关实验视频

Updated: Feb 21, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

针对慢性代谢性疾病的重组活生物疗法:挑战和机遇

Prajwal Swamy¹, Lakhwinder Singh², Priya Sehrawat¹

¹Chemistry & Pharmacology lab, Centre for Drug Discovery, BRIC, Translational Health Sciences and Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.

Progress in molecular biology and translational science

|February 19, 2026

概括

重组活生物治疗产品 (rLBPs) 显示出治疗慢性代谢疾病 (CMD) 的前景,如肥胖和糖尿病. 这些工程微生物提供有针对性的疗法,尽管面临当前的挑战,但可能会改变临床管理模式.

科学领域:

微生物学微生物学
代谢疾病代谢疾病
生物治疗药物生物治疗药物

背景情况:

慢性代谢性疾病 (CMDs),包括肥胖,2型糖尿病 (T2DM),代谢功能障碍相关的脂肪性肝病 (MASLD) 和心血管疾病 (CVDs),构成了重大的全球健康挑战.
疾病的发展与复杂的因素有关,如持续的代谢,炎症和肠道微生物组功能障碍.

研究的目的:

为CMDs的管理提供重组活生物治疗产品 (rLBPs) 的概述.
突出CMD的早期rLBPs开发,并讨论相关的挑战和机遇.

主要方法:

审查当前文献和开创性例子的rLBPs在CMDs的早期发展.
对rLBP发展中的科学,技术和监管障碍的分析.
探索推进rLBP疗法的潜在机会.

主要成果:

识别rLBPs作为工程微生物,旨在实现in situ治疗效果 (代谢,抗炎,激素).
证明rLBPs作为CMD常规疗法的有希望的替代方案.
在临床前或临床早期的CMD开发中,具体的rLBP候选者的概述.

结论:

rLBPs代表了一种新的治疗策略,有可能彻底改变CMD管理.
解决科学,技术和监管方面的挑战对于rLBPs的成功临床转化至关重要.
需要进一步的研究和开发,才能充分实现rLBPs在打击慢性代谢疾病日益增长的负担中的治疗潜力.

关键词:

生物产品是生物产品.慢性代谢性疾病慢性代谢性疾病活生生的生物疗法.基于微生物组的治疗方法再组合活生物治疗药物合成生物学合成生物学

更多相关视频

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Recombinant DNA

Recombinant DNA

The Central Dogma

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...